It Is All in the Blood: The Multifaceted Contribution of Circulating Progenitor Cells in Diabetic Complications

door Fadini, Gian Paolo, Avogaro, Angelo
Gepubliceerd in 2012

Comparative effectiveness of liraglutide in the treatment of type 2 diabetes

door Rigato, Mauro, Fadini, Gian Paolo
Gepubliceerd in 2014

Mechanisms of ectopic calcification: implications for diabetic vasculopathy

door Avogaro, Angelo, Fadini, Gian Paolo
Gepubliceerd in Cardiovasc Diagn Ther (2015)

How to interpret the role of SDF-1α on diabetic complications during therapy with DPP-4 inhibitors

door Fadini, Gian Paolo, Avogaro, Angelo
Gepubliceerd in Cardiovasc Diabetol (2018)

The pleiotropic cardiovascular effects of dipeptidyl peptidase‐4 inhibitors

door Avogaro, Angelo, Fadini, Gian Paolo
Gepubliceerd in Br J Clin Pharmacol (2018)

Modulation of Obesity and Insulin Resistance by the Redox Enzyme and Adaptor Protein p66(Shc)

door Ciciliot, Stefano, Fadini, Gian Paolo
Gepubliceerd in Int J Mol Sci (2019)

First Isolation of Burkholderia cepacia from a Deep Neck Abscess in a Diabetic Patient Successfully Treated with Hyperbaric Oxygen

door Fadini, Gian Paolo, Tiengo, Antonio, Avogaro, Angelo
Gepubliceerd in 2005

Critical re-evaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use

door Fadini, Gian Paolo, Losordo, Douglas, Dimmeler, Stefanie
Gepubliceerd in 2012

Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System

door Fadini, Gian Paolo, Sarangdhar, Mayur, Avogaro, Angelo
Gepubliceerd in BMJ Open Diabetes Res Care (2018)

Pharmacovigilance Evaluation of the Association Between DPP-4 Inhibitors and Heart Failure: Stimulated Reporting and Moderation by Drug Interactions

door Fadini, Gian Paolo, Sarangdhar, Mayur, Avogaro, Angelo
Gepubliceerd in Diabetes Ther (2018)

Managing diabetes in diabetic patients with COVID: where do we start from?

door Avogaro, Angelo, Bonora, Benedetta, Fadini, Gian Paolo
Gepubliceerd in Acta Diabetol (2021)

Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence

door Bonora, Benedetta Maria, Avogaro, Angelo, Fadini, Gian Paolo
Gepubliceerd in Diabetes Metab Syndr Obes (2020)

Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients a...

door Morieri, Mario Luca, Avogaro, Angelo, Fadini, Gian Paolo
Gepubliceerd in Cardiovasc Diabetol (2020)

Long-Acting Injectable GLP-1 Receptor Agonists for the Treatment of Adults with Type 2 Diabetes: Perspectives from Clinical Practice

door Morieri, Mario Luca, Avogaro, Angelo, Fadini, Gian Paolo
Gepubliceerd in Diabetes Metab Syndr Obes (2020)

Circulating Levels of Endothelial Progenitor Cell Mobilizing Factors in The Metabolic Syndrome

door Jialal, Ishwarlal, Fadini, Gian Paolo, Pollock, Kari, Devaraj, Sridevi
Gepubliceerd in 2010

Vascular Stem and Progenitor Cells in Diabetic Complications

door Fadini, Gian Paolo, Madeddu, Paolo, Waltenberger, Johannes, Fiorina, Paolo
Gepubliceerd in 2012

The impact of glucose-lowering medications on cardiovascular disease

door Avogaro, Angelo, De Kreutzenberg, Saula Vigili, Fadini, Gian Paolo
Gepubliceerd in Cardiovasc Endocrinol Metab (2018)

Reduced Rates of Hypoglycemia in Type 1 or Type 2 Diabetes After Switching to Insulin Degludec: Results from the Italian Cohort of the ReFLeCT Study

door Fadini, Gian Paolo, Giordano, Carla, Salvi, Laura, Nicolucci, Antonio
Gepubliceerd in Diabetes Ther (2020)

SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system

door Bonora, Benedetta Maria, Raschi, Emanuel, Avogaro, Angelo, Fadini, Gian Paolo
Gepubliceerd in Cardiovasc Diabetol (2021)

The emerging role of circulating calcifying cells in the bone-vascular axis

door Fadini, Gian Paolo, Rattazzi, Marcello, Matsumoto, Tomoyuki, Asahara, Takayuki, Khosla, Sundeep
Gepubliceerd in 2012